HACKENSACK, N.J., Sept. 1, 2020 /PRNewswire/ — Royal Biologics, an ortho-biologics company specializing in the research and advancement of autologous and live cellular solutions, today announced the completed acquisition of FIBRINET, from Vertical Spine LLC. The acquisition comes as part of Royal Biologics’ strategic initiative to add novel technologies to its growing portfolio of autologous and live cellular …